Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Dementia Clinical Trials

A listing of Dementia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (651) clinical trials

Enrolling men and women who have signs of early stage Alzheimer's Disease. The clinical trial is evaluating whether an investigational combined treatment slows down, arrests, or reverses early stage Alzheimer's disease.

Phase N/A

A global research study needs people aged 50 to 85 concerned by their memory changes. If you or someone you know is experiencing memory loss or has early Alzheimer’s disease, you may qualify and receive at no cost: Investigational drug Study-related care from a local study doctor Reimbursement for travel ...

Phase N/A

The purpose of this study is to evaluate whether treatment with JNJ-54861911 slows cognitive decline compared with placebo treatment, as measured by a composite cognitive measure, the Preclinical Alzheimer Cognitive Composite (PACC), in amyloid-positive participants who are asymptomatic at risk for developing Alzheimer's dementia.

Phase N/A

A research study is evaluating an investigational medication for mild Alzheimer’s Disease dementia. This research study may be an option for your loved one if: They are 55-85 years of age They have a diagnosis of mild Alzheimer’s Disease dementia All their medication is stable for at least 30 days ...

Phase N/A

The purpose of the study is to determine whether lowering systolic blood pressure and cholesterol, alone or in combination with aerobic exercise, can improve memory function of the brain in older adults at higher risk for developing dementia. This study will last 2 years. There are outpatient visits (2-5 hours ...

Phase N/A

SPRI is currently participating in a multi-center, 24-month clinical evaluation of an investigational drug for people suffering from mild cognitive impairment (MCI) or mild Alzheimer’s disease (AD).

Phase N/A

A Phase III, Randomized, Placebo-Controlled, Double Blind Clinical Trial to study the Efficacy and Safety of MK-8931 in Subjects with Amnestic Mild Cognitive Impairment (aMCI) due to Alzheimer’s Disease (prodromal AD).M

Phase N/A

People who may develop Alzheimer's Disease are asked to participate in a research study being conducted by New York University School of Medicine.

Phase N/A